Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent.
about
Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in miceIncreasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouseRecombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in miceCoadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke-no influence on functional outcome and blood-brain barrier disruptionBlood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic strokeEfficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study.Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia.Infarct volume after hyperacute infusion of hypertonic saline in a rat model of acute embolic stroke.Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model.Does inhibiting Sur1 complement rt-PA in cerebral ischemia?Alfimeprase: a novel recombinant direct-acting fibrinolytic.Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemiaMinocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential.Leukoaraiosis as an outcome predictor in the acute and subacute phases of stroke.Impact of leukoaraiosis on parenchymal hemorrhage in elderly patients treated with thrombolysis.Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke.Safety evaluation of a recombinant plasmin derivative lacking kringles 2-5 and rt-PA in a rat model of transient ischemic strokeMore extensive white matter hyperintensity is linked with higher risk of remote intracerebral hemorrhage after intravenous thrombolysis.Endogenous tissue plasminogen activator increases hemorrhagic transformation induced by heparin after ischemia reperfusion in rat brains.
P2860
Q27320059-65E9FFF7-B799-4E0D-A737-3D3440199DE9Q33530141-62C7CC4E-5DEE-4FB8-84D3-031B13E3A849Q33581243-D68EAED3-C5E3-4502-9619-57B43DA68363Q33643959-E32CCA3F-2F36-439D-9691-8FA02D1D0AA3Q33684529-3FAD0B6B-DE7D-4974-A3E6-A9258E0384CEQ33714865-6D3F9E3D-7290-4E5D-B81A-544D48D698B4Q33978307-A5490681-3937-43DA-B7CC-3BF0DA6A0A40Q34171344-2A1F44AB-574A-491F-AFC4-357C279F2B4AQ34377250-88AE0A28-F361-4CA9-8755-CEEBDB6226D9Q35248340-3D337DAE-0279-4B0B-BBD8-8224831111D3Q36426567-230319E8-49F7-49DE-AB96-9C4ED51BF0F0Q36708324-F26FCE83-7812-45A3-82EC-829B37022C79Q37230709-FE9406B9-C624-41C5-9770-81FF3364EA25Q37367536-7C1147BF-7E25-41D7-9206-9DF8CC64665CQ38614484-C8A22346-E99A-4A31-A328-E924AF0AAC55Q39570573-3645B120-2E21-4F32-B687-2BBA9AA38753Q39635208-24AABEF0-4A05-4B7F-8A59-305D0654D3F1Q42271721-7DF30CE9-5289-4706-9A37-BF6187F0717EQ46092213-01921C1E-908D-4C8E-BFC7-42EAAA4CDC6FQ48691531-BEED36D1-6B99-4127-B407-93B15D242180
P2860
Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Tissue plasminogen activator m ...... terial and thrombolytic agent.
@ast
Tissue plasminogen activator m ...... terial and thrombolytic agent.
@en
type
label
Tissue plasminogen activator m ...... terial and thrombolytic agent.
@ast
Tissue plasminogen activator m ...... terial and thrombolytic agent.
@en
prefLabel
Tissue plasminogen activator m ...... terial and thrombolytic agent.
@ast
Tissue plasminogen activator m ...... terial and thrombolytic agent.
@en
P2093
P921
P1476
Tissue plasminogen activator m ...... terial and thrombolytic agent.
@en
P2093
Abdelhaq Rami
Christian Foerch
Helmuth Steinmetz
Matthias Sitzer
Michael Schroeter
Timo Kahles
Tobias Neumann-Haefelin
P304
P356
10.1016/J.VPH.2005.07.008
P577
2005-09-26T00:00:00Z